- Home
- AMLX vs ALEX Comparison
AMLX vs ALEX Comparison
Compare AMLX & ALEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMLX | ALEX |
|---|---|---|
| Founded | 2014 | 1870 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMLX | ALEX |
|---|---|---|
| Price | $15.72 | $20.75 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | $17.43 | ★ $21.00 |
| AVG Volume (30 Days) | ★ 1.8M | 616.1K |
| Earning Date | 03-03-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 6.75% |
| EPS Growth | N/A | ★ 65.09 |
| EPS | N/A | ★ 1.01 |
| Revenue | N/A | ★ $226,062,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.12 |
| P/E Ratio | ★ N/A | $20.51 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.60 | $15.07 |
| 52 Week High | $17.49 | $21.03 |
Technical Indicators
Market Signals| Indicator | AMLX | ALEX |
|---|---|---|
| Relative Strength Index (RSI) | 65.02 | 71.74 |
| Support Level | $12.08 | $20.61 |
| Resistance Level | $17.49 | $20.80 |
| Average True Range (ATR) | 1.01 | 0.06 |
| MACD | 0.50 | -0.14 |
| Stochastic Oscillator | 73.42 | 61.36 |
Price Performance
Historical ComparisonAbout AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
About ALEX Alexander & Baldwin Inc. REIT Holding Company
Alexander & Baldwin Inc is a Hawaii commercial real estate company. The group owns, operates, and manages million square feet of retail, industrial, and office space in Hawaii. It is a real estate investment trust (REIT) and the owner of grocery and drug-anchored retail centers in the state. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces, and also urban ground leases in Hawaii, thereby accounting for a majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.